Summary of "Дубынин МФК весна 2021 Химия мозга 11 алкоголь"

Lecture overview

This lecture (Lecture 11, presenter: Дубынин) covers how ethanol (C2H5OH) affects the brain, the dose-dependent behavioral effects, metabolism and genetic variability, dependence and withdrawal syndromes, public-health and historical context, and approaches to treatment and harm reduction.

Key properties of ethanol

Ethanol is a small, amphiphilic molecule that dissolves in both water and lipids.
It crosses cell membranes easily and distributes throughout the body, including the brain.
Ethanol is not a classical neurotransmitter but strongly affects brain function by:
- Intercalating into lipid bilayers and altering membrane protein (receptor, channel, pump, enzyme) function.
- Directly interacting with certain receptor proteins (for example, GABA-A) and indirectly modulating many neurotransmitter systems.

Mechanisms of action (molecular and cellular)

Ethanol partitions into membranes and perturbs membrane structure, altering the conformation and function of embedded proteins.
Direct modulation:
- Potentiates GABA-A receptor–mediated inhibition (major mechanism for sedative/depressant effects).
- Affects other receptors and ion channels, including NMDA receptors and various ligand-gated ion channels.
Reward pathway activation:
- Small doses stimulate mesolimbic dopaminergic pathways (ventral tegmental area → nucleus accumbens → cortex), producing disinhibition and reinforcement.

Dose-dependent behavioral and physiological effects

Low / small doses (~10–30 g ethanol):
- Disinhibition, psychomotor activation, increased sociability.
- Largely mediated by increased dopamine system activity.
Medium doses (~20–80 g ethanol):
- Sedative/depressant effects dominate: enhanced GABAergic inhibition, depressed cortical function, reduced attention and poorer judgment.
High doses (>60–80 g and above):
- Global disruption of synaptic function, severe intoxication, risk of poisoning.
- Possible aggressive or bizarre behaviors.
- Acetaldehyde toxicity contributes to hangover and other adverse effects.
Very large doses can produce respiratory/CNS depression and life‑threatening consequences.

Dependence types and withdrawal syndromes

Two distinct dependence/withdrawal patterns are emphasized:

Dopamine-type dependence
- Associated with stimulant-like reward from repeated low-dose drinking.
- Repeated use can alter dopamine synapses, producing craving and low motivation/anergia during withdrawal.
- Presentation is similar to stimulant-type dependence (craving, reduced drive when sober).
GABA/inhibitory-type dependence
- Associated with repeated medium-to-high doses.
- Chronic alcohol use induces adaptive suppression of inhibitory neurotransmission.
- Withdrawal causes overexcitation: tremor, hallucinations, and, in severe cases, delirium tremens (potentially life‑threatening).
- Requires medical management in severe cases.

Metabolism and genetic variability

Metabolic pathway: ethanol → acetaldehyde → acetate (acetic acid) → CO2 + H2O.
Two main enzymes:
- Alcohol dehydrogenase (ADH): converts ethanol to acetaldehyde.
- Aldehyde dehydrogenase (ALDH): converts acetaldehyde to acetate.
Acetaldehyde is toxic and largely responsible for hangover symptoms.
Genetic polymorphisms in ADH and ALDH strongly affect sensitivity to alcohol, hangover severity, intoxication pattern, and addiction risk.

Illustrative genetic/enzyme scenarios:

Both ADH and ALDH highly active:
- Rapid clearance of ethanol and acetaldehyde → little intoxication/hangover.
ADH good, ALDH poorer:
- Acetaldehyde accumulates → hangover, unpleasant effects; common pattern.
ALDH very poor:
- Immediate, intense adverse reaction to alcohol → most people avoid drinking.
ADH poor (slow ethanol conversion):
- Ethanol persists longer → pleasant effects, minimal hangover → higher risk of rapid addiction development.

Pharmacological blockade of ALDH (disulfiram/“Antabuse”) produces an aversive reaction to alcohol and can be used in treatment with informed consent.

Treatment, outcomes, and management

Inpatient rehabilitation:
- First-attempt 1-year abstinence rates are modest (~15–20%).
- Repeated treatment attempts and personal motivation increase chances of long-term success.
Pharmacological aversion therapy:
- Disulfiram inhibits ALDH and causes an aversive reaction when alcohol is consumed; must be used with informed consent.
- Historical observation: industrial exposures (vulcanization workers) led to the discovery of disulfiram-like effects.
Medical management of severe withdrawal:
- GABA-type withdrawal (risk of delirium tremens) can be life‑threatening and requires medical supervision and appropriate pharmacotherapy.

Harm reduction and short-term hangover management (lecture tips)

Preventive / immediate measures discussed in the lecture:
- Take an analgesic (aspirin or analgin) in the evening rather than waiting until morning.
- Rehydrate and correct electrolytes (water, electrolyte solutions).
- Consider digestive enzymes and vitamins.
- Light/moderate exercise.
Harm note: these are practical suggestions discussed in the lecture; clinical decisions (medications, dosing) should follow medical advice.

Other risks: solvents and inhalants

Solvents and inhalants (ethers, acetone, nitrous oxide, glues) are particularly dangerous for adolescents.
They cross membranes easily and can cause rapid neuronal death and severe, fast neurocognitive decline.
These substances pose acute and long-term neurological risks distinct from ethanol.

Public-health, historical, and cultural points

Alcohol has deep historical and cultural roots: fermentation and beer in ancient Sumer, wine in Biblical stories, and medieval Arab alchemists developing distillation.
Alcohol is a major public-health burden:
- Fetal alcohol syndrome, accidents, chronic disease, economic costs, and reduced life expectancy.
Country-level trends (example: Russia)
- Consumption levels have fluctuated across the 20th century; WHO estimates show recent declines from earlier peaks.
Policy considerations:
- Prohibition and outright bans tend to produce black markets and other harms.
- Taxation, regulation, and other policy tools are complex and have trade-offs.

Historical, cultural, and anecdotal references from the lecture

Ancient sources and images: fermented fruit, Sumerian imagery, Biblical Noah (Genesis).
Word history: “alcohol” and distillation traced to medieval Arab alchemists.
Cultural anecdotes: Vladimir Svyatoslavich’s religious choice cited as an illustrative historical reference to alcohol and culture.
Literary example: Robert Sheckley story used as an allegory for dependence and perceived biological “need” for alcohol.
Cultural depiction of delirium tremens: historically framed as devils, later as aliens, then back to devils—used to illustrate changing cultural narratives.
Industrial history: discovery of aversive effects among vulcanization workers informed development of aversive therapy drugs.

Speakers and sources referenced

Lecture presenter: Дубынин (Lecture 11 — alcohol and brain chemistry).
Biblical source: Book of Genesis (Noah).
Historical/cultural references: ancient Sumerian images; Giovanni Bellini (painting referenced); medieval Arab alchemists.
Institutions and researchers: National Center for Narcology (NNC Narcology); Academician Irina Petrovna Anokhina (research on genetic predisposition to addiction).
International data: World Health Organization (WHO) — alcohol consumption statistics.
Literature: Robert Sheckley (fiction referenced).
Medical/pharmacological: Disulfiram (Antabuse) — ALDH inhibitor; naloxone (analogy referenced).
Industrial anecdote: German vulcanization workers (historical observation leading to aversive therapy concept).